Thu. 28 Mar 2024, 11:36pm ET
Benzinga
Earnings, Earnings Beats, News
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(2.88) by 39.58 percent. This is a 68.48 percent increase over losses of $(5.52) per share from the same period last year. The company reported $7.16 million in sales this quarter.